Stentys Reports 2013 Financial Results

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

STENTYS (FR0010949404 – STNT), a medical technology company commercializing the world’s first and only Self-Apposing® stent to treat acute myocardial Infarction (AMI), today announced its annual results for the financial year to December 31, 2013, approved by the Board of Directors at its meeting on March 6, 2014.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC